EMBO Molecular Medicine
Copyright © 2009Published on behalf of EMBO by Wiley-Blackwell
- View Current Issue
In this issue
RNAi-based therapeutics
Katrin Tiemann and John Rossi discuss the current state, the challenges and prospects of RNAi-based therapies.
PINK1
Timely and comprehensive, this review discusses the multiple functions of PINK1 in health and disease.
PRIMARY RESEARCH
Novel disease-causing Kir6.2 mutations
HP1α overexpression in cancer
Current issue in full
Early View Highlights
TNF-regulated miR-155 in B-cell lymphoma
Michael David's lab shows that in B-cell lymphomas TNF-regulated miR-155 targets SHIP1. The work highlights the feasibility of anti-TNFα therapy as a treatment for such tumours. Read about it
A marker for Aβ-42
Masa Okochi and colleagues show that in the CSF APL1β28 is a surrogate marker for Aβ-42 production offering hope of early test and better treatment of Alzheimer's disease. Read about it
EDITORIALS
Read a set of editorials from EMBO and our Editors:
Meet our senior editors
.jpg)
Journal Menu
